SOTERA HEALTH COMPANY Business Acquisition, Pro Forma Net Income (Loss)
SOTERA HEALTH COMPANY (SHC) reported Business Acquisition, Pro Forma Net Income (Loss) of -$34.69 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2022-03-01
- SOTERA HEALTH COMPANY business acquisition, pro forma net income (loss) for the quarter ending 2021-03-31 was -$889.00K.
- SOTERA HEALTH COMPANY business acquisition, pro forma net income (loss) for the quarter ending 2020-12-31 was -$29.70M.
- SOTERA HEALTH COMPANY business acquisition, pro forma net income (loss) for the quarter ending 2020-09-30 was $575.00K.
- SOTERA HEALTH COMPANY business acquisition, pro forma net income (loss) for the quarter ending 2020-06-30 was $8.45M.
- SOTERA HEALTH COMPANY business acquisition, pro forma net income (loss) for fiscal 2021 was -$34.69M.
- SOTERA HEALTH COMPANY business acquisition, pro forma net income (loss) for fiscal 2020 was -$21.96M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$34.69M 10-K · filed 2022-03-01 | |||
| 2021-03-31 | -$889.00K 10-Q · filed 2021-05-13 | -$30.59M derived: sum of 2 quarters · filed 2022-03-01 | -$30.01M derived: sum of 3 quarters · filed 2022-03-01 | -$21.56M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | -$29.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$29.13M derived: sum of 2 quarters · filed 2022-03-01 | -$20.67M derived: sum of 3 quarters · filed 2022-03-01 | -$21.96M 10-K · filed 2022-03-01 |
| 2020-09-30 | $575.00K 10-Q · filed 2021-11-10 | $9.03M derived: sum of 2 quarters · filed 2021-11-10 | $7.74M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $8.45M 10-Q · filed 2021-08-12 | $7.16M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |